SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-021777
Filing Date
2020-02-14
Accepted
2020-02-14 16:15:32
Documents
1
Group Members
FRED KNOLLGAKASA HOLDINGS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm207993d1_sc13ga.htm SC 13G/A 84242
  Complete submission text file 0001104659-20-021777.txt   85896
Mailing Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017
Business Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017 212-808-7474
Knoll Capital Management, LP (Filed by) CIK: 0001325083 (see all company filings)

IRS No.: 133476926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Subject) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88716 | Film No.: 20620042
SIC: 2834 Pharmaceutical Preparations